+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sarepta Therapeutics - logo

Sarepta Therapeutics is a biopharmaceutical company that focuses on the development of RNA-based therapeutics for the treatment of rare neuromuscular diseases. The company offers EXONDYS 51, a disease-modifying therapy for the treatment of duchenne muscular dystrophy (DMD). It also develops SRP-4045 and SRP-4053, which are exon skipping clinical product candidates for the treatment of DMD. Sarepta Therapeutics, Inc. was founded in 1980 and is headquartered in Cambridge, Massachusetts.

From
RNA Therapy Market - Global Forecast 2025-2030 - Product Thumbnail Image

RNA Therapy Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 192 Pages
  • Global
From
From
Oligonucleotide Therapy Market Report 2025 - Product Thumbnail Image

Oligonucleotide Therapy Market Report 2025

  • Report
  • March 2025
  • 250 Pages
  • Global
From
From
Duchenne Muscular Dystrophy - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Duchenne Muscular Dystrophy - Global Clinical Trials Review, 2025

  • Clinical Trials
  • April 2025
  • 302 Pages
  • Global
From
Casimersen - Drug Insight and Market Forecast - 2030 - Product Thumbnail Image

Casimersen - Drug Insight and Market Forecast - 2030

  • Report
  • August 2020
  • 80 Pages
  • Global
From
Mitoxantrone Hydrochloride Market - Global Forecast to 2030 - Product Thumbnail Image

Mitoxantrone Hydrochloride Market - Global Forecast to 2030

  • Report
  • August 2025
  • 187 Pages
  • Global
From
From
Collaboration Deals in Pharmaceuticals 2020-2025 - Product Thumbnail Image

Collaboration Deals in Pharmaceuticals 2020-2025

  • Report
  • September 2025
  • 950 Pages
  • Global
From
From
Translational Regenerative Medicine Market Report 2024-2034 - Product Thumbnail Image

Translational Regenerative Medicine Market Report 2024-2034

  • Report
  • February 2024
  • 270 Pages
  • Global
From
From
Loading Indicator